source
- Updated: AstraZeneca sinks on unexpected heart drug trial failureAstraZeneca’s shares dropped in early trading Thursday after a heart disease treatment it is developing with Ionis Pharmaceuticals surprisingly failed in a late-stage trial. The companies had aimed…Endpoints · 19d ago↗ source
- Prime Medicine wins spat with Beam Therapeutics over AATD candidatePrime Medicine is headed for the clinic after winning a dispute with Beam Therapeutics, another gene editing biotech with roots in the same lab. Arbitrators determined that a 2019 contract between…Endpoints · 20d ago↗ source
- HHS lays groundwork for new FDA rule on releasing CRLsThe Trump administration is pushing the FDA to cement the details behind its proactive public release of rejection letters sent to pharma companies. The push comes as an HHS spokesperson confirmed…